In a recent in vitro study of angiotensin II-stimulated cardiomyocytes, dapagliflozin activated SIRT1 and attenuated HF development by inhibiting the transformation of fibroblasts into myofibroblasts as well as fibroblast migration [94]. The gene discussed is SIRT1; the disease is hydrops fetalis.